Overview

A Study to Evaluate the Effect of RO7204239 on Insulin Sensitivity and Muscle Composition in Participants With Type 2 Diabetes Mellitus (T2DM) and Overweight or Obesity

Status:
RECRUITING
Trial end date:
2027-03-03
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to assess the effect of RO7204239 on insulin sensitivity versus placebo in participants with T2DM and obesity or overweight.
Phase:
PHASE1
Details
Lead Sponsor:
Hoffmann-La Roche